Industry Partners

Beijing Genomics Institute (BGI) Australia

Beijing Genomics Institute was founded in 1999 with the vision of using genomics to benefit mankind and has since become the largest genomic organisation in the world. With a focus on research and applications in the healthcare, agriculture, conservation, and environmental fields, BGI has a proven track record of innovative, high profile research. BGI Australia was launched in May 2017.

Brisbane Veterinary Specialist Centre

BVSC is a large veterinary practice in Brisbane with a purpose built, state-of-the- art veterinary hospital providing a comprehensive range of oncology services with surgical, medical and radiation oncology. 

Clarity Pharmaceuticals Pty. Ltd.

Clarity Pharmaceutical’s activities centre on innovative radiopharmaceutical technology, developing targeted therapies and assisting in the drug development pipeline of novel therapies for companies globally. The company’s proprietary SAR technology allows antibodies to be radiolabelled and visualised using PET imaging. 

Genesis Care Theranostics Pty Ltd.

Theranostics Australia was established in May 2015 with the aim of providing patients with contemporary cancer treatment options. Theranostics Australia, now fully owned by GenesisCare, is developing targeted molecular diagnostic imaging and radiotherapeutic agents for oncology and neurosciences.

Glytherix Pty Ltd.

GlyTherix Ltd is an Australian immuno-oncology company specializing in therapeutics for solid tumors, including prostate, bladder and pancreas. GlyTherix is developing Miltuximab® for the targeted treatment of a number of cancers. 


I-MED Queensland Pty Ltd

I-MED radiology network is the leading private diagnostic imaging provider in Australia with a vision to be the most respected and trusted medical imaging specialists in the world.

Intellidesign Pty Ltd

Intellidesign is an award-winning market leader in the design and manufacture of custom electronic devices used in a wide variety of applications including industrial process control, medical, defence and transport. Intellidesign operates from an AS9100 certified one-stop “concept-design-manufacture” facility in Brisbane.

Inter-K Peptide Therapeutics Pty. Ltd.


Inter-K Peptide Therapeutics is a preclinical biotechnology SME based in Sydney that was established 12 years ago to develop peptide-based immunotherapeutic agents for the treatment of major global diseases such as cancer.



Polarize offers a flexible, cryogen-free polarizer for pre-clinical Hyperpolarized Metabolic MR and NMR research.

Siemens Healthineers


Siemens Healthcare Australia is part of Siemens’ global health care portfolio, Siemens Healthineers. As one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics and medical information technology, Siemens is committed to research and invests an above industry average part of its revenue back into Research and Development.